Home

munn konkurranse respekt teva products respiratory Human Bli gift Sterk vind

Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue

Teva Reports First Quarter 2020 Financial Results | Business Wire
Teva Reports First Quarter 2020 Financial Results | Business Wire

Logo Teva Pharmaceutical Industries Brand TEVA Pharmaceuticals CR, S.r.o.,  PNG, 720x577px, Logo, Blue, Brand, Light, Material
Logo Teva Pharmaceutical Industries Brand TEVA Pharmaceuticals CR, S.r.o., PNG, 720x577px, Logo, Blue, Brand, Light, Material

Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler®  (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir®  Digihaler® (fluticasone propionate) Inhalation Powder
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder

Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business  Wire
Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire

Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of  its Respiratory Digital Health Platform | Business Wire
Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of its Respiratory Digital Health Platform | Business Wire

Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Pharmaceuticals (@TevaUSA) / Twitter

Teva Announces U.S. Launch of QVAR® RediHaler™ (Beclomethasone Dipropionate  HFA) Inhalation Aerosol | Business Wire
Teva Announces U.S. Launch of QVAR® RediHaler™ (Beclomethasone Dipropionate HFA) Inhalation Aerosol | Business Wire

research2guidance - Digital respiratory ecosystem: companies are  positioning themselves to capture the respiratory market potential
research2guidance - Digital respiratory ecosystem: companies are positioning themselves to capture the respiratory market potential

Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Pharmaceuticals (@TevaUSA) / Twitter

Teva Reports Third Quarter 2022 Financial Results
Teva Reports Third Quarter 2022 Financial Results

Guilherme Safioti - Medical Director, GMA Connected Respiratory - Teva  Pharmaceuticals, SE
Guilherme Safioti - Medical Director, GMA Connected Respiratory - Teva Pharmaceuticals, SE

Teva Pharmaceuticals buys smart inhaler company Gecko Health Innovations |  MobiHealthNews
Teva Pharmaceuticals buys smart inhaler company Gecko Health Innovations | MobiHealthNews

Complex Generics Made Simple — the Respiratory Segment | Teva api
Complex Generics Made Simple — the Respiratory Segment | Teva api

Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In  Sensors – ProAir® Digihaler™ | SnackSafely.com
Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com

Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug  Development and Chronic Disease Management with
Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with

Teva tries to breathe new life into pipeline with MicroDose purchase |  Evaluate
Teva tries to breathe new life into pipeline with MicroDose purchase | Evaluate

The World of the API Podcast: Respiratory APIs | Teva api
The World of the API Podcast: Respiratory APIs | Teva api

Teva Q3 profit misses estimates, tightens FY19 forecast | AlphaStreet
Teva Q3 profit misses estimates, tightens FY19 forecast | AlphaStreet

Teva's Unorthodox Strategy For The Respiratory Market — Will It Work
Teva's Unorthodox Strategy For The Respiratory Market — Will It Work

Drugmaker Teva may pay as much as $3.6 billion in U.S. opioid settlement |  Reuters
Drugmaker Teva may pay as much as $3.6 billion in U.S. opioid settlement | Reuters

TEVA PHARMACEUTICALS – Pharmacyapozona
TEVA PHARMACEUTICALS – Pharmacyapozona

Teva launches connected inhaler for asthma, COPD - Drug Delivery Business
Teva launches connected inhaler for asthma, COPD - Drug Delivery Business

Teva Pharmaceuticals To Buy Gecko Health Innovations
Teva Pharmaceuticals To Buy Gecko Health Innovations

FDA Approves Two Breath-actuated Asthma Meds from Teva | RT
FDA Approves Two Breath-actuated Asthma Meds from Teva | RT

Teva unloads plant, U.S. OTC line to PL Developments | Fierce Pharma
Teva unloads plant, U.S. OTC line to PL Developments | Fierce Pharma